Aditxt, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Aditxt, Inc. (ADTX) had Stockholders' Equity Attributable to Noncontrolling Interest of -$1.90 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-05-20
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$1.90M.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$1.66M.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$1.13M.
- 2025-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$964.19K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-03-31 | -$1.90M 10-Q · filed 2026-05-20 |
| 2025-12-31 | -$1.66M 10-Q · filed 2026-05-20 |
| 2025-09-30 | -$1.13M 10-Q · filed 2025-11-18 |
| 2025-06-30 | -$964.19K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$825.34K 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$583.18K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$262.64K 10-Q · filed 2024-11-18 |
| 2024-06-30 | -$222.84K 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$148.57K 10-Q · filed 2024-05-20 |
| 2023-12-31 | -$9.61K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |